A Massachusetts-based biotech company is stealing the show so far during Tuesday’s session after it announced that its investigational drug IMM-1-104 has received orphan...

To read the full story on AllPennyStocks.com, click here.

Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Immuneering Charts.
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Immuneering Charts.